Metabolic Imaging of Head and Neck Cancer Organoids

Head and neck cancer patients suffer from toxicities, morbidities, and mortalities, and these ailments could be minimized through improved therapies. Drug discovery is a long, expensive, and complex process, so optimized assays can improve the success rate of drug candidates. This study applies optical imaging of cell metabolism to three-dimensional in vitro cultures of head and neck cancer grown from primary tumor tissue (organoids). This technique is advantageous because it measures cell metabolism using intrinsic fluorescence from NAD(P)H and FAD on a single cell level for a three-dimensional in vitro model. Head and neck cancer organoids are characterized alone and after treatment with standard therapies, including an antibody therapy, a chemotherapy, and combination therapy. Additionally, organoid cellular heterogeneity is analyzed quantitatively and qualitatively. Gold standard measures of treatment response, including cell proliferation, cell death, and in vivo tumor volume, validate therapeutic efficacy for each treatment group in a parallel study. Results indicate that optical metabolic imaging is sensitive to therapeutic response in organoids after 1 day of treatment (p<0.05) and resolves cell subpopulations with distinct metabolic phenotypes. Ultimately, this platform could provide a sensitive high-throughput assay to streamline the drug discovery process for head and neck cancer.

[1]  Hans Clevers,et al.  Organoid cultures for the analysis of cancer phenotypes. , 2014, Current opinion in genetics & development.

[2]  Alex J Walsh,et al.  Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. , 2014, Cancer research.

[3]  N. Ramanujam,et al.  Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH. , 2005, Cancer research.

[4]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .

[5]  Alex J Walsh,et al.  Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. , 2013, Cancer research.

[6]  Jacques Bernier,et al.  Molecular therapy in head and neck oncology , 2009, Nature Reviews Clinical Oncology.

[7]  N. Restifo,et al.  Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.

[8]  L. Norton,et al.  Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C F Dewey,et al.  Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Ramanujam.  Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. , 2000, Neoplasia.

[11]  Nathan O. Kaplan,et al.  Fluorescence of Pyridine Nucleotides in Mitochondria , 1962 .

[12]  Watt W Webb,et al.  Two-photon fluorescence spectroscopy and microscopy of NAD(P)H and flavoprotein. , 2002, Biophysical journal.

[13]  S. Rees,et al.  Principles of early drug discovery , 2011, British journal of pharmacology.

[14]  J. Adams,et al.  High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions. , 1995, Analytical biochemistry.

[15]  Z. Fan,et al.  The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. , 2010, Cancer research.

[16]  K. Münger,et al.  Intrinsic fluorescence and redox changes associated with apoptosis of primary human epithelial cells. , 2006, Journal of biomedical optics.

[17]  N. Ramanujam,et al.  In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia , 2007, Proceedings of the National Academy of Sciences.

[18]  M. Goldwasser,et al.  Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  K. Dittmann,et al.  Human skin fibroblasts in vitro differentiate along a terminal cell lineage. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[21]  D. Ball,et al.  Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft , 1997, Cancer Chemotherapy and Pharmacology.

[22]  F. Bootz,et al.  Tissue Engineering of Human Salivary Gland Organoids , 2002, Acta oto-laryngologica.

[23]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[24]  R. Hoffman,et al.  Drug response of head and neck tumors in native-state histoculture. , 1991, Archives of otolaryngology--head & neck surgery.

[25]  J. Grandis,et al.  Emerging drugs to treat squamous cell carcinomas of the head and neck , 2010, Expert opinion on emerging drugs.

[26]  A Trotti,et al.  Toxicity in head and neck cancer: a review of trends and issues. , 2000, International journal of radiation oncology, biology, physics.

[27]  Amy T. Shah,et al.  Optical Metabolic Imaging of Treatment Response in Human Head and Neck Squamous Cell Carcinoma , 2014, PloS one.

[28]  P. Sacks.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck , 1996, Cancer and Metastasis Reviews.

[29]  Alex J. Walsh,et al.  Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response , 2015, Pancreas.

[30]  C. Badoual,et al.  Head and Neck: Squamous cell carcinoma: an overview , 2012 .

[31]  Melissa C. Skala,et al.  An automated image processing routine for segmentation of cell cytoplasms in high-resolution autofluorescence images , 2014, Photonics West - Biomedical Optics.

[32]  Alex J. Walsh,et al.  Optical metabolic imaging quantifies heterogeneous cell populations. , 2015, Biomedical optics express.

[33]  F. Pampaloni,et al.  The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.

[34]  Amy T. Shah,et al.  In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment , 2015, Neoplasia.

[35]  C. R. Leemans,et al.  Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  V. Virador,et al.  In vitro three‐dimensional (3D) models in cancer research: An update , 2013, Molecular carcinogenesis.

[37]  B. Chance,et al.  Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals. , 1979, The Journal of biological chemistry.

[38]  O. Riesterer,et al.  Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  S. Linder,et al.  Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA , 2007, International journal of cancer.